499 related articles for article (PubMed ID: 7759555)
1. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
2. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
3. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
4. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
5. Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis.
Lugemwa FN; Esko JD
J Biol Chem; 1991 Apr; 266(11):6674-7. PubMed ID: 2016281
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
Tumova S; Hatch BA; Law DJ; Bame KJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
[TBL] [Abstract][Full Text] [Related]
7. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1995 Jan; 316(1):227-34. PubMed ID: 7840621
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
Moscatelli D
J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
[TBL] [Abstract][Full Text] [Related]
9. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach.
Gleizes PE; Noaillac-Depeyre J; Amalric F; Gas N
Eur J Cell Biol; 1995 Jan; 66(1):47-59. PubMed ID: 7750519
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor.
Vigny M; Ollier-Hartmann MP; Lavigne M; Fayein N; Jeanny JC; Laurent M; Courtois Y
J Cell Physiol; 1988 Nov; 137(2):321-8. PubMed ID: 2973466
[TBL] [Abstract][Full Text] [Related]
13. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
16. Interaction of basic fibroblast growth factor (FGF-2) with nonresponsive HeLa cells.
Gannoun-Zaki L; Pieri I; Badet J; Barritault D
Exp Cell Res; 1994 Aug; 213(2):375-82. PubMed ID: 8050494
[TBL] [Abstract][Full Text] [Related]
17. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
[TBL] [Abstract][Full Text] [Related]
18. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M; Urbinati C; Presta M
J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
[TBL] [Abstract][Full Text] [Related]
19. Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products.
Mani K; Belting M; Ellervik U; Falk N; Svensson G; Sandgren S; Cheng F; Fransson LA
Glycobiology; 2004 May; 14(5):387-97. PubMed ID: 14718369
[TBL] [Abstract][Full Text] [Related]
20. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.
Foxall C; Holme KR; Liang W; Wei Z
Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
